首页> 美国卫生研究院文献>Epidemiology and Infection >Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey or human diploid cell substrates.
【2h】

Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey or human diploid cell substrates.

机译:施用在猴子或人二倍体细胞底物中制备的三价口服脊髓灰质炎疫苗后抗体反应和病毒脱落的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Nineteen (22.9%) of 83 sera collected before vaccination from adult volunteers aged 21-64 years were without neutralizing antibody to poliomyelitis at levels of 0.15 i.u./ml for types I and II and 0.1 i.u./ml for type III. Some correlations were found between the history of previous vaccination and the presence of antibody but these were not well defined. Vaccination with a single dose of trivalent oral polio vaccine elicited fourfold or greater antibody responses to one or more poliomyelitis types in 53 (63.9%) volunteers, the percentage antibody resposnes being inversely related to the titre of antibody present before vaccination. Types I, II or III poliomyelitis virus were recovered from 76.8% of faecal samples collected 1 week after vaccination. The percentage recovery progressively declined thereafter until virus was recovered from 10.5% of samples collected 6 weeks after vaccination. Type for type, the titres and percentages of antibody responses and virus shedding in faeces were similar following trivalent oral poliomyelitis vaccines whether prepared in monkey or human diploid cell substrates. Some change in reproductive capacity temperature (r.c.t./40) marker was found in faecal isolates from volunteers vaccinated with monkey kidney and human diploid grown vaccines but no change in 'd' marker was found.
机译:在接种前从21-64岁的成年志愿者中收集的83份血清中,有19份(22.9%)没有中和脊髓灰质炎的抗体,I型和II型为0.15 i.u./ml,III型为0.1 i.u./ml。在先前的疫苗接种史和抗体的存在之间发现了一些相关性,但是还没有很好的定义。在53名(63.9%)志愿者中,单剂量的三价口服脊髓灰质炎疫苗接种会引起针对一种或多种脊髓灰质炎类型的四倍或更高的抗体应答,抗体残留百分率与疫苗接种前存在的抗体滴度成反比。接种1周后收集的粪便样本中有76.8%回收了I,II或III型脊髓灰质炎病毒。此后回收率逐渐下降,直到从接种疫苗后6周收集的10.5%的样品中回收病毒为止。对于三型口服脊髓灰质炎疫苗,无论是在猴还是人二倍体细胞基质中制备,粪便中抗体反应的滴度和滴度,抗体反应的滴度和百分比与病毒脱落相似。在接种了猴肾和人类二倍体生长疫苗的志愿者的粪便分离物中发现了生殖能力温度(r.c.t./40)标记的某些变化,但未发现“ d”标记的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号